Latest News

Four teams of leading scientists from the UK, Germany and the Netherlands will collaborate on projects to accelerate progress in the detection and treatment of cardiovascular diseases. The British Heart Foundation (BHF), the German Centre for Cardiovascular Research (DZHK) and...

Magnetocardiography is a simple and safe examination of the heart. It does not currently play an important role in cardiology. However, this could change: a recently published study from the German Heart Centre at the Charité shows that the method could play an important role...

The so-called "gene scissors" CRISPR/Cas9 can be used to specifically modify DNA: Researchers worldwide hope to be able to use it to better combat cancer and hereditary diseases such as congenital heart defects. Scientists at Heidelberg University have now succeeded in optimizing...

For young researchers, leading their junior research group is an important step towards scientific independence. Heart-lung specialist Dr. Jana Grune of the German Heart Center at Charité in Berlin and molecular biologist Dr. Pieterjan Dierickx from the Max Planck Institute for...

A DZHK research team at the University Medical Center Mainz has discovered a new signaling pathway of the coagulation system that controls scar formation after a heart attack. If this signaling pathway could be inhibited, heart attacks could heal with less subsequent damage.

Prof. Benjamin Meder has accepted the call to the W3 professorship "Precision Digital Health" at Heidelberg University. Within the framework of the research professorship, his focus is on molecular and digital biomarkers, the use of artificial intelligence in everyday clinical...

The German Center for Cardiovascular Research is centralizing its biospecimens collections, which are currently stored at 60 sites. Therefore, it is looking for two biobanks as scientific cooperation partners. Applications are now open to all German biobanks.

Heart tissue consists of different cell types. If the tissue is healthy, the cells "chat" extensively with their neighbors, exchanging information via receptors and ligands. In old and diseased hearts, this no longer seems to work well. A young research team from Frankfurt has...

How does the medical agent get to the inflamed articular cartilage? And how can gene therapeutics be targeted to the vascular wall to prevent an aneurysm in the heart? For an active ingredient or a gene vector to do any good, it has to be delivered to the right place - hydrogels...

How can patients who have already suffered a stroke be protected from having another stroke? At least for a particular group of stroke patients, it makes sense to record the risk for atrial fibrillation. If the stake for atrial fibrillation is high, they can be protected from...